PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Social Anxiety 3,287 Disease Disease Infection 766,637 6 0.00 -1.00 0.00 0.47
B-R1 90 Target Disease Infection 766,637 1 0.00 -0.99 0.01 0.51
Adenosine A1 Receptor 1,432 Target Disease Infection 766,637 4 0.00 -1.00 0.00 0.48
EPHA4 357 Target Disease Infection 766,637 2 0.00 -1.00 0.01 0.49
Glutathione S-Transferase Theta-1 70 Target Disease Infection 766,637 1 0.00 -0.99 0.01 0.51
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Infection 766,637 2 0.00 -1.00 0.01 0.50
DNAJB1 44 Target Disease Infection 766,637 1 0.00 -0.99 0.02 0.52
CAMK2A 42 Target Disease Infection 766,637 1 0.00 -0.99 0.02 0.52
Polycystic Ovarian Syndrome 1,615 Disease Disease Infection 766,637 7 0.00 -1.00 0.00 0.49
Sodium Channel Nav1.8 31 Target Disease Infection 766,637 1 0.00 -0.98 0.03 0.53
Droperidol 1,957 Drug Disease Infection 766,637 8 0.00 -1.00 0.00 0.49
Epigen 27 Target Disease Infection 766,637 1 0.00 -0.98 0.04 0.53
DAPK2 27 Target Disease Infection 766,637 1 0.00 -0.98 0.04 0.53
Carcinoma Bladder 25 Disease Disease Infection 766,637 1 0.00 -0.98 0.04 0.53
Estrogen Receptor Beta 1,924 Target Disease Infection 766,637 9 0.00 -1.00 0.00 0.49
Avastin (Bevacizumab)- FDA 207 Drug Disease Infection 766,637 3 0.00 -0.99 0.01 0.51
Collagenase-3 367 Target Disease Infection 766,637 4 0.00 -0.99 0.01 0.51
Doxylamine 206 Drug Disease Infection 766,637 3 0.00 -0.99 0.01 0.51
Separation Anxiety 1,096 Disease Disease Infection 766,637 7 0.00 -1.00 0.01 0.50
DDR2 194 Target Disease Infection 766,637 3 0.00 -0.99 0.02 0.51
Chorismate Synthase 85 Target Disease Infection 766,637 2 0.00 -0.99 0.02 0.52
Extrapyramidal Disorder 81 Disease Disease Infection 766,637 2 0.00 -0.99 0.02 0.52
Complement Decay-Accelerating Factor 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53
AMAC-1 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53
Fabry Disease 1,876 Disease Disease Infection 766,637 10 0.00 -1.00 0.01 0.49
Histamine H1 Receptor 1,170 Target Disease Infection 766,637 8 0.00 -1.00 0.01 0.50
Anesthesia Local 18 Disease Disease Infection 766,637 1 0.00 -0.97 0.06 0.53
CCNB1 160 Target Disease Infection 766,637 3 0.00 -0.99 0.02 0.52
Doxazosin 1,316 Drug Disease Infection 766,637 9 0.00 -1.00 0.01 0.50
Complement Component C3c 15 Target Disease Infection 766,637 1 0.00 -0.97 0.07 0.54
FABP3 134 Target Disease Infection 766,637 3 0.00 -0.99 0.02 0.52
Arava (Leflunomide)- FDA 14 Drug Disease Infection 766,637 1 0.00 -0.96 0.07 0.54
Parkinsons Disease 124 Disease Disease Infection 766,637 3 0.00 -0.99 0.02 0.52
Phosphodiesterase 4b 54 Target Disease Infection 766,637 2 0.00 -0.98 0.04 0.53
Alpha (Prolastin)- FDA 13 Drug Disease Infection 766,637 1 0.00 -0.96 0.08 0.54
High Affinity Nerve Growth Factor Receptor 47 Target Disease Infection 766,637 2 0.00 -0.98 0.04 0.53
Carcinoma Squamous Cell 47 Disease Disease Infection 766,637 2 0.00 -0.98 0.04 0.53
Dopamine Receptor D3 45 Target Disease Infection 766,637 2 0.00 -0.98 0.04 0.53
BAFFR 44 Target Disease Infection 766,637 2 0.00 -0.98 0.05 0.53
ACTG1 41 Target Disease Infection 766,637 2 0.00 -0.98 0.05 0.53
BLK 255 Target Disease Infection 766,637 5 0.00 -0.99 0.02 0.52
Anakinra (Kineret)- FDA 10 Drug Disease Infection 766,637 1 0.00 -0.95 0.10 0.54
ADRBK1 10 Target Disease Infection 766,637 1 0.00 -0.95 0.10 0.54
ENO2 87 Target Disease Infection 766,637 3 0.00 -0.98 0.03 0.53
Phobias 1,578 Disease Disease Infection 766,637 13 0.00 -1.00 0.01 0.50
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Infection 766,637 1 0.00 -0.94 0.11 0.54
CD62L/L-Selectin 8 Target Disease Infection 766,637 1 0.00 -0.94 0.12 0.55
Atosiban 274 Target Disease Infection 766,637 6 0.00 -0.99 0.02 0.52
Muscle Fatigue 3,245 Disease Disease Infection 766,637 21 0.00 -1.00 0.01 0.50
Alitretinoin (Panretin)- FDA 7 Drug Disease Infection 766,637 1 0.00 -0.93 0.14 0.55